Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lenexa, Kansas 66219


This randomized, open-label study will evaluate the effect of food, and the effect of omeprazole and ranitidine on danoprevir co-administered with ritonavir. Volunteers will be assigned to one of two treatment groups. Volunteers in both groups will receive oral doses of danoprevir and ritonavir. In addition, volunteers in group 2 will receive oral doses of omeprazole and ranitidine. The anticipated time of the study is approximately 6 weeks.


Inclusion Criteria: - Adult healthy volunteers, aged 18 to 45 years, inclusive - Weight >/= 50.0 kg - Body Mass Index (BMI) 18.0 to 32.0 kg/m2, inclusive Exclusion Criteria: - Presence of any active or chronic disease - Abnormal blood pressure - Abnormal resting heart rate - Abnormal ECG values - History of any clinically significant cardiovascular or cerebrovascular disease - Current smokers or subjects that have discontinued smoking < 6 months prior to first dose of study drug - Positive for hepatitis B, hepatitis C or HIV - Positive test for drugs of abuse or alcohol - Positive result for H. pylori - Regular use of antacids, H-2 blockers, proton pump inhibitors, or any investigational drug within 30 days of first dose of study medication - History of clinically significant gastrointestinal disease



Primary Contact:

Study Director
Clinical Trials
Hoffmann-La Roche

Backup Contact:


Location Contact:

Lenexa, Kansas 66219
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.